Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival episode artwork

EPISODE · Aug 27, 2015 · 5 MIN

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

from GRACEcast · host cancerGRACE Meetings

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

Episode metadata supplied by the publisher feed · Published Aug 27, 2015

Embed this episode

NOW PLAYING

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

0:00 5:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 5 minutes long.

When was this GRACEcast episode published?

This episode was published on August 27, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!